Apyx Medical Corporation

DB:BOV Stock Report

Market Cap: €51.8m

Apyx Medical Management

Management criteria checks 2/4

Apyx Medical's CEO is Charlie Goodwin, appointed in Dec 2017, has a tenure of 6.92 years. total yearly compensation is $1.26M, comprised of 38.2% salary and 61.8% bonuses, including company stock and options. directly owns 0.24% of the company’s shares, worth €123.91K. The average tenure of the management team and the board of directors is 0.9 years and 5.3 years respectively.

Key information

Charlie Goodwin

Chief executive officer

US$1.3m

Total compensation

CEO salary percentage38.2%
CEO tenure6.9yrs
CEO ownership0.2%
Management average tenureless than a year
Board average tenure5.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Charlie Goodwin's remuneration changed compared to Apyx Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$28m

Jun 30 2024n/an/a

-US$28m

Mar 31 2024n/an/a

-US$23m

Dec 31 2023US$1mUS$483k

-US$19m

Sep 30 2023n/an/a

-US$15m

Jun 30 2023n/an/a

-US$16m

Mar 31 2023n/an/a

-US$21m

Dec 31 2022US$2mUS$483k

-US$23m

Sep 30 2022n/an/a

-US$19m

Jun 30 2022n/an/a

-US$18m

Mar 31 2022n/an/a

-US$16m

Dec 31 2021US$2mUS$450k

-US$15m

Sep 30 2021n/an/a

-US$15m

Jun 30 2021n/an/a

-US$14m

Mar 31 2021n/an/a

-US$15m

Dec 31 2020US$2mUS$450k

-US$12m

Sep 30 2020n/an/a

-US$16m

Jun 30 2020n/an/a

-US$16m

Mar 31 2020n/an/a

-US$16m

Dec 31 2019US$2mUS$450k

-US$20m

Sep 30 2019n/an/a

-US$18m

Jun 30 2019n/an/a

-US$15m

Mar 31 2019n/an/a

-US$14m

Dec 31 2018US$1mUS$400k

-US$11m

Sep 30 2018n/an/a

-US$10m

Jun 30 2018n/an/a

-US$12m

Mar 31 2018n/an/a

-US$15m

Dec 31 2017US$2mUS$15k

-US$14m

Compensation vs Market: Charlie's total compensation ($USD1.26M) is above average for companies of similar size in the German market ($USD471.55K).

Compensation vs Earnings: Charlie's compensation has been consistent with company performance over the past year.

CEO

Charlie Goodwin (58 yo)

6.9yrs

Tenure

US$1,261,470

Compensation

Mr. Charles D. Goodwin II, also known as Charlie, has been Chief Executive Officer and Director of Apyx Medical Corporation (formerly known as Bovie Medical Corporation) since December 15, 2017 and serves...

Leadership Team

NamePositionTenureCompensationOwnership
Charles Goodwin
President6.9yrsUS$1.26m0.24%
€ 123.9k
Matthew Hill
CFO, Treasurer & Secretaryless than a yearUS$445.95k0.021%
€ 10.8k
Moshe Citronowicz
Senior Vice President12.8yrsUS$538.31k1.21%
€ 628.5k
Stavros Vizirgianakis
Executive Chairmanless than a yearno data4.64%
€ 2.4m
Shawn Roman
Chief Operating Officerno datano datano data

0.9yrs

Average Tenure

55yo

Average Age

Experienced Management: BOV's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Charles Goodwin
President6.9yrsUS$1.26m0.24%
€ 123.9k
Stavros Vizirgianakis
Executive Chairmanless than a yearno data4.64%
€ 2.4m
Lawrence Waldman
Lead Independent Director13.7yrsUS$162.56k0.11%
€ 59.1k
Brian Kinney
Member of Medical Advisory Board5.3yrsno datano data
Gregory Konesky
Member of Scientific Advisory Boardno dataUS$9.30kno data
Yuval Carmel
Member of Scientific Advisory Boardno datano datano data
Minnie Baylor-Henry
Independent Director5.3yrsUS$116.56k0%
€ 0
Dennis Chi
Member of Medical Advisory Board7.8yrsno datano data
Diane Duncan
Member of Medical Advisory Board6.5yrsno datano data
Paul Ruff
Member of Medical Advisory Board5.3yrsno datano data
Richard Gentile
Member of Medical Advisory Board5.3yrsno datano data
Edward Zimmerman
Member of Medical Advisory Board5.3yrsno datano data

5.3yrs

Average Tenure

69yo

Average Age

Experienced Board: BOV's board of directors are considered experienced (5.3 years average tenure).